When we excluded women who were pregnant or receiving oral contraceptive or hormone replacement therapy – all possible causes of blood clots – the risk for women was reduced by 55 percent.

Methods Totally, 71 cases with the history of at least two pregnancy losses and 93 fertile parous women without pregnancy loss and thrombosis history were selected as the RPL and control group.